Literature DB >> 20351748

Association of the 19S proteasomal ATPases with the ATPase-binding domain of CIITA is essential for CIITA stability and MHC class II expression.

Kavita Purnanda Bhat1, Agnieszka Dorota Truax, Jeanne Kaye Brooks, Susanna Fletcher Greer.   

Abstract

Major histocompatibility class II (MHC class II) molecules are glycoproteins that present extracellular antigens to CD4(+) T cells and are essential for initiation of adaptive immune responses. MHC class II expression requires recruitment of a master regulator, the class II transactivator (CIITA), to the MHC class II promoter. Others and we have earlier linked CIITA to the ubiquitin-proteasome system by showing that mono-ubiquitination of CIITA increases its transactivity, whereas poly-ubiquitination of CIITA leads to its degradation. We have further shown that the 26S proteasome also has non-proteolytic functions in MHC class II transcription, as 19S ATPase subunits of the 26S proteasome positively regulate MHC class II transcription and are necessary for stable promoter binding of CIITA. Although these basic requirements of the proteasome to initiate MHC class II transcription are known, how CIITA is recruited, stabilized, and degraded remains unclear. Here, we identify a novel N-terminal 19S ATPase-binding domain of CIITA. The ATPase-binding domain lies within the proline/serine/threonine-rich region of CIITA and encompasses a majority of the CIITA degron sequence. Absence of the ATPase-binding domain increases the half-life of CIITA, but blocks MHC class II surface expression, indicating that CIITA requires interaction with the 19S ATPases for both appropriate deployment and destruction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351748     DOI: 10.1038/icb.2010.45

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  5 in total

1.  Development of potent class II transactivator gene delivery systems capable of inducing de novo MHC II expression in human cells, in vitro and ex vivo.

Authors:  M L Palma; P Duangkhae; B Douradinha; I F T Viana; P O Rigato; R Dhalia; R B Mailliard; S M Barratt-Boyes; E J M Nascimento; T M Oshiro; A J da Silva Duarte; E T A Marques
Journal:  Gene Ther       Date:  2017-04-17       Impact factor: 4.184

2.  Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III.

Authors:  Yves B Beaulieu; Jorge A Leon Machado; Sylvain Ethier; Luc Gaudreau; Viktor Steimle
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 3.  The MHC Class II Transactivator CIITA: Not (Quite) the Odd-One-Out Anymore among NLR Proteins.

Authors:  Jorge Alfonso León Machado; Viktor Steimle
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

4.  A Spontaneous H2-Aa Point Mutation Impairs MHC II Synthesis and CD4+ T-Cell Development in Mice.

Authors:  Yun Zhao; Juan Xiong; Hai-Xia Chen; Min Zhang; Li-Na Zhou; Yin-Fang Wu; Wei-Jie Li; Xia Fei; Fei Li; Chen Zhu; Wen Li; Song-Min Ying; Lie Wang; Zhi-Hua Chen; Hua-Hao Shen
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

5.  Expression regulation of major histocompatibility complex class I and class II encoding genes.

Authors:  Peter J van den Elsen
Journal:  Front Immunol       Date:  2011-10-04       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.